The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction
- Conditions
- Erectile Dysfunction
- Interventions
- Procedure: Li-ESWT
- Registration Number
- NCT05043896
- Lead Sponsor
- Dr. Soetomo General Hospital
- Brief Summary
to compare the effect of combination of li-eswt and pde-5 inhibitor to pde-5 alone in erectile dysfunction patients
- Detailed Description
Comparing the effect of Combination therapy (Li-ESWT combined with PDE5-inhibitor) vs SIngle therapy (PDE5-inhibitor) in mild to moderate Erectile Dysfunction patients.
Parameters used for comparation are EHS score, IIEF-5 score, VEGF level and PSV
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 30
- Mild to Moderate Erectile dysfunction
- Married
- Sexually active
- Consenting to participate in the trial
- Psychological problems
- Spinal injury
- History of malignancy
- Penile anatomy abnormalities
- Allergic and Contraindications to tadalafil
- On anti-mitotic drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Combination therapy Tadalafil 2.5Mg Tab Li-ESWT + tadalafil Combination therapy Li-ESWT Li-ESWT + tadalafil Single Therapy Tadalafil 2.5Mg Tab tadalafil only
- Primary Outcome Measures
Name Time Method Erectile Hardness Score (EHS) 4 weeks Developed in 1998, the EHS is a single-item Likert scale that men can use on their own.
The tool asks them to consider the question "How would you rate the hardness of your erection?" and select one of the following options:
0 Penis does not enlarge
1. Penis is larger, but not hard
2. Penis is hard, but not hard enough for penetration
3. Penis is hard enough for penetration, but not completely hard
4. Penis is completely hard and fully rigid
The EHS score was taken pre and post interventionInternational Index of Erectile Function (IIEF-5) score 4 weeks IIEF-5 is a tool for ED (Erectile Dysfunction)diagnosis. The possible scores for the IIEF-5 range from 5 to 25, and ED was classified into five categories based on the scores: severe (5-7), moderate (8-11), mild to moderate (12-16), mild (17-21), and no ED (22-25)
IIEF-5 score was taken pre and post interventionPeak Systolic Velocity (PSV) 4 weeks PSV was measured in cm/s, by using Doppler Ultrasonography. The probe is located at the penis, to be precise in the penoscrotal junction, to measure the velocity of the blood flow in the cavernous arteries.
The test was done in flaccid state of the penis Measurement was taken by an experienced ultrasonographer in the radiology unit. Measurement was taken pre and post interventionVascular Endothelial Growth Factor (VEGF) level in plasma 4 weeks VEGF was measured in pg/ml. VEGF test were done by blood test in the laboratory using the VEGF-A ELISA Kit.
Blood for tests were drawn pre and post test
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
dr. Soetomo General Hospital
🇮🇩Surabaya, Jawa Timur, Indonesia